Cassia fistula oil was investigated for antifungal activities against standard and clinical isolates of Candida species. Gas chromatography coupled with mass spectrometric (GC-MS) analysis of C. fistula oil revealed the presence of antimicrobial compounds like β-sitosterol, stigmasterol, ergosterol, betulinic acid, lupeol, fucosterol, α-amyrin and friedelin. The minimum inhibitory concentration (MIC) of the pulp and seed oils ranged between 250-300 and 350-500 μg/mL respectively. Both oils also inhibited by ≥63.8% ergosterol bio-synthesis in Candida cell wall {fluconazole (standard) ≥89.1%)}. The MICs were significantly correlated with the ergosterol content decrease in the cell wall (Student's t test p ≤ 0.005). We can, therefore, conclude that active compounds are present in Cassia fistula oil that primarily target ergosterol biosynthesis in Candida cell wall.
ShaoPL, HuangLM, HsuehPR. (2007) Recent advances and challenges in the treatment of invasive fungal infections. International Journal of Antimicrobial Agents, 30, 487–95;
2.
AhmadA, KhanA, ManzoorN, KhanLA. (2010) Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microbial Pathogenesis, 48, 35–41;
3.
LupettiA, DanesiR, CampaM, Del-TaccaM, KellyS., (2002) Molecular basis of resistance to azole antifungals. Trends in Molecular Medicine, 8, 76–81;
4.
KhanA, AhmadA, ManzoorN, KhanLA. (2010) Antifungal activities of Ocimum sanctum essential oil and its lead molecules. Natural Product Communications, 5, 345–349.
5.
MoshahidAR, IrshadM, GamalEH, SalaemBY. (2009) Bioefficacies of Cassia fistula: An Indian labrum. African Journal of Pharmacy and Pharmacology, 3, 287–292;
6.
IrshadM, SinghM, RizviMMA. (2010) Assessment of anthelmintic activity of Cassia fistula L. Middle-East Journal of Scientific Research, 5, 346–349;
7.
AkanmuMA, IwalewaEO, LujobaAA, AdelusolaKA. (1994) Toxicity potentials of Cassia fistula fruits as laxative with reference to Senna. African Journal of Biomedical Research, 7, 23–26;
8.
IrshadM, SinghM, ZafaryabM, RizviMMA. (2012) Comparative analysis of the antioxidant activity of Cassia fistula extracts. International Journal of Medicinal Chemistry, doi:10.1155/2012/157125.
9.
IrshadM, ShreazS, ManzoorN, KhanLA, RizviMMA. (2011) Anticandidal activity of Cassia fistula and its effect on ergosterol biosynthesis. Pharmaceutical Biology, 49, 727–733.
10.
LingWH, JonesPJH. (1995) Dietary phytosterols: a review of metabolism, benefits and side effects. Life Science, 57, 195–206;
11.
YasukawaK, TakidoM, MatsumotoT, TakeuchiM, NakagawaS., (1991) Sterol and triterpene derivatives from plants inhibit the effects of tumour promoter and sitosterol and betulinic acid inhibit tumour formation in mouse skin two stage carcinogenesis. Oncology, 41, 72–76;
12.
RaichtR, CohenB, FazziniE., (1980) Protective effect of plant sterols against chemically induced colon tumours in rats. Cancer Research, 40, 403–405.
13.
GuptaR, SharmaAK, DobhalMP, SharmaMC, GuptaRS. (2011) Antidiabetic and antioxidant potential of β-sitosterol in streptozotocin-induced experimental hyperglycemia. Journal of Diabetes, 3, 29–37.
14.
MbamboB, OdhavB, MohanlallV., (2012) Antifungal activity of stigmasterol, sitosterol and ergosterol from Bulbine natalensis Baker (Asphodelaceae). Journal of Medicinal Plants Research, DOI: 10.5897/JMPR12.151
15.
Atta-Ur-Rahman, ChoudharyMI, MajeedA, ShabbirM, GhaniU, ShameelM., (1997) A succinylanthranilic acid ester and other bioactive constituents of Jolyna laminarioides. Phytochemistry, 46, 1215–1218;
16.
LeeYS, ShinKH, KimBK, LeeS., (2004) Anti-diabetic activities of fucosterol from Pelvetia siliquosa. Archives of Pharmacal Research, 27, 1120–1122.
YouYJ, NamNH, KimY, BaeKH, AhnBZ. (2003) Antiangiogenic activity of lupeol from Bombax ceiba. Phytotherapy Research, 17, 341–344.
22.
AgarwalRB, RangariVD. (2003) Antiinflammatory and antiarthritic activities of lupeol and 19a-H lupeol isolated from Strobilanthus callosus and Strobilanthus ixiocephala roots. Indian Journal of Pharmacology, 35, 384–387.
23.
ChandramuC, ManoharRD, KrupadanamDG, DashavanthaRV. (2003) Isolation, characterization and biological activity of betulinic acid and ursolic acid from Vitex negundo L. Phytotherapy Research, 17, 129–134.
24.
FuldaS. (2008) Betulinic acid for cancer treatment and prevention. International Journal of Molecular Science, 9, 1096–1107.
25.
MannA, IbrahimK, OyewaleAO, AmupitanJO, FatopeMO, OkogunJI. (2011) Antimycobacterial friedelane-terpenoid from the root bark of Terminalia avicennioides. American Journal of Chemistry, 1, 52–55.
26.
AntonisamyP, DuraipandiyanV, IgnacimuthuS., (2011) Anti-inflammatory, analgesic and antipyretic effects of friedelin isolated from Azima tetracantha Lam. in mouse and rat models. The Journal of Pharmacy and Pharmacology, 63, 1070–1077.
27.
RingbomT, HussU, StenholmA, FlockS, SkatteboelP, PereraP, BohlinL., (2001) COX-2-inhibitory effects on naturally occurring and modified fatty acids. Journal of Natural Products, 64, 745–749;
28.
KimJY, ParkHD, ParkE, ChonJW, ParkYK. (2009) Growth-inhibitory and proapoptotic effects of alpha-linolenic acid on estrogen-positive breast cancer cells. Annals of the New York Academy of Sciences, 1171, 190–195.
29.
AhmadA, KhanA, ManzoorN, KhanLA. (2010) Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Microbial Pathogenesis, 48, 35–41;
30.
CLSI/NCCLS. (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-3rd Edition. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
31.
Arthington-SkaggsBA, JradiH, DesaiT, MorrisonCJ. (1999) Quantitation of ergosterol content: Novel method for determination of fluconazole susceptibility of Candida albicans. Journal of Clinical Microbiology, 37, 3332–3337;
32.
BreivikON, OwadesJL. (1957) Spectrophotometric semi-micro determination of ergosterol in yeast. Journal of Agriculture and Food Chemistry, 5, 360–363.
